Accelerating the expansion of what we know about COVID-19 is critical to conquering the pandemic. The world needs faster testing, faster vaccine development, faster results – but how?
Researchers all over the world are racing to develop models for understanding the novel coronavirus behavior and move toward timely deployment of safe and efficacious therapies.
Identifying and linking viral mutations to observations in geographic origin, infectivity, and symptoms is helping researchers model how the virus has spread and how it may behave.
Collaborations within the greater virology community are working to develop an antibody discovery program and get it into the clinic.
Faster results and faster action are needed to help prevent the spread of COVID-19. See how laboratories are reducing time it takes for results from days to hours.
For Research Use Only. Not for use in diagnostic procedures.
Disclaimer: Agilent products are NOT approved for COVID-19 testing, diagnosis, treatment, or mitigation. Agilent has not validated a product to detect the novel coronavirus.